These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Comparisons of dose-response data for various standard and recombinant DNA-derived human interferons. Stebbing N; May L J Virol Methods; 1982 Dec; 5(5-6):309-15. PubMed ID: 6298267 [TBL] [Abstract][Full Text] [Related]
43. Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state. Tan YH; Schneider EL; Tischfield J; Epstein CJ; Ruddle FH Science; 1974 Oct; 186(4158):61-3. PubMed ID: 4371269 [TBL] [Abstract][Full Text] [Related]
44. An inhibitor of interferon action: II. Biological properties of the IFN-gamma-associated inhibitor of interferon action. Lefkowitz EJ; Fleischmann WR J Interferon Res; 1985; 5(1):101-10. PubMed ID: 2985715 [TBL] [Abstract][Full Text] [Related]
45. [Inhibition of interferon activity by ouabain]. Lebon P; Moreau MC C R Acad Hebd Seances Acad Sci D; 1973 Jun; 276(23):3061-4. PubMed ID: 4353204 [No Abstract] [Full Text] [Related]
46. A small fraction of cells communicates the maximal interferon sensitivity to a population. Blalock JE Proc Soc Exp Biol Med; 1979 Oct; 162(1):80-4. PubMed ID: 228315 [No Abstract] [Full Text] [Related]
47. Chromosome 21 and the cell growth inhibitory effect of human interferon preparations. Tan YH Nature; 1976 Mar; 260(5547):141-3. PubMed ID: 176593 [No Abstract] [Full Text] [Related]
49. Physical dependence to morphine diminishes the interferon response in mice. Lorenzo P; Portolés A; Beneit JV; Ronda E; Portolés A Immunopharmacology; 1987; 14(2):93-9. PubMed ID: 2448267 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of interferon action by plant lectins. Besancon F; Ankel H Nature; 1974 Aug; 250(5469):784-6. PubMed ID: 4370104 [No Abstract] [Full Text] [Related]
51. Effect of viruses and interferon on chick embryo otocyst cultures. Shikani AH; Richtsmeier WJ Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):1020-3. PubMed ID: 1720934 [TBL] [Abstract][Full Text] [Related]
52. PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunity. Epstein LB; Cline MJ; Merigan TC Cell Immunol; 1971 Dec; 2(6):602-13. PubMed ID: 4360795 [No Abstract] [Full Text] [Related]
53. [Degradation by phytohemagglutinin of the antiviral state induced by interferon]. Pauloin A; Chany-Fournier F; Epstein L; Chany C C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(12):1119-22. PubMed ID: 194719 [TBL] [Abstract][Full Text] [Related]
54. Cell-membrane phospholipase C is involved in inducing the antiviral effect of interferon. Popescu LM; Cernescu C; Moraru II; Constantinescu SN; Baltà F; Manciulea M; Bràiloiu E; Buzilà L Biosci Rep; 1989 Oct; 9(5):531-9. PubMed ID: 2508782 [TBL] [Abstract][Full Text] [Related]
55. [Isolation of somatic cell hybrids by using a specific interferon- virus method of selection]. Narovlianskii AN; Amchenkova AM; Shcheglovitova ON; Khesin IaE Vopr Virusol; 1985; 30(2):244-50. PubMed ID: 2988215 [No Abstract] [Full Text] [Related]
56. Comparative pathogenicity of vesicular stomatitis virus and its plaque type mutants. Shechmeister IL; Streckfuss J; St John R Arch Gesamte Virusforsch; 1967; 21(2):127-32. PubMed ID: 4298421 [No Abstract] [Full Text] [Related]
57. Reduction in antiviral activity of human beta interferon by gallic acid. Osborne LC; Peeler JT; Archer DL Infect Immun; 1981 Sep; 33(3):769-74. PubMed ID: 6169644 [TBL] [Abstract][Full Text] [Related]
58. [Tissue antagonist of interferon : murine substance similar to plant lectins]. Chany-Fournier F; Pauloin A; Chany C C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(8):941-4. PubMed ID: 199376 [TBL] [Abstract][Full Text] [Related]